Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual Inhibition of KRASG12D and Pan-ERBB Is Synergistic in Pancreatic Ductal Adenocarcinoma
Kevin Christian Montecillo Gulay, Xinlian Zhang, Vasiliki Pantazopoulou, et al.
Cancer Research (2023) Vol. 83, Iss. 18, pp. 3001-3012
Open Access | Times Cited: 36

Showing 26-50 of 36 citing articles:

ZBTB11 Depletion Targets Metabolic Vulnerabilities in K-Ras Inhibitor Resistant PDAC
Nathan L. Tran, Jiewei Jiang, Min Ma, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
MGST1 facilitates novel KRASG12D inhibitor resistance in KRASG12D-mutated pancreatic ductal adenocarcinoma by inhibiting ferroptosis
Chungui Xu, Weihao Lin, Qi Zhang, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 2
MRTX1133’s promise for treating KRASG12D-mutant pancreatic cancer
Malak Haidar, Patrick Jacquemin
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 4, pp. 2002-2005
Open Access | Times Cited: 1
Combination of farnesyl-transferase inhibition with KRAS G12D targeting breaks down therapeutic resistance in pancreatic cancer
Eszter Molnár, Marcell Baranyi, Krisztina Andrea Szigeti, et al.
Pathology & Oncology Research (2024) Vol. 30
Open Access | Times Cited: 1
KRAS, a New Target for Precision Medicine in Colorectal Cancer?
Alice Boilève, Cristina Smolenschi, Aurélien Lambert, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3455-3455
Open Access | Times Cited: 1
Multi-omics pan-cancer study of SPTBN2 and its value as a potential therapeutic target in pancreatic cancer
Hongliang Chang, Hong Chen, Taiheng Ma, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
B7 homolog 3 in pancreatic cancer
Dijana Perović, Marija Dušanović Pjević, Vladimir Perović, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 31, pp. 3654-3667
Open Access
Targeting KRAS‐mutant pancreatic cancer through simultaneous inhibition of KRAS, MEK, and JAK2
Satoru Miyazaki, Masato Kitazawa, Satoshi Nakamura, et al.
Molecular Oncology (2024)
Open Access
Development of Highly Sensitive Anti-Mouse Epidermal Growth Factor Receptor 2 Monoclonal Antibodies for Flow Cytometry
Tsunenori Ouchida, Hiroyuki Suzuki, Tomohiro Tanaka, et al.
(2023)
Open Access | Times Cited: 1
Development of Highly Sensitive Anti-Mouse HER2 Monoclonal Antibodies for Flow Cytometry
Tsunenori Ouchida, Hiroyuki Suzuki, Tomohiro Tanaka, et al.
International Journal of Translational Medicine (2023) Vol. 3, Iss. 3, pp. 310-320
Open Access
Molecular underpinnings of pancreatic cancer: Innovations in treatment and future perspectives
Mesut Tez, Eda Şahingöz, Fahri Martlı
Gastrointestinal Tract (2023) Vol. 1
Open Access
Previous Page - Page 2

Scroll to top